Loss-of-function mutations in TP53 correlate with hyperactivation of PIK3CA and the PI3K pathway, resulting in worse prognoses for head and neck squamous cell carcinoma patients[99]. Here, PIK3CA is linked to head and neck squamous cell carcinoma.